Literature DB >> 32038908

Myeloid-derived suppressor cell-dependent inhibition of B cell responses in non-small cell lung cancer.

Rui Li1, Steven M Dubinett1.   

Abstract

Entities:  

Year:  2019        PMID： 32038908      PMCID： PMC6987369          DOI： 10.21037/tlcr.2019.04.10

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  20 in total

1.  Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.

Authors:  Steven L Highfill; Yongzhi Cui; Amber J Giles; Jillian P Smith; Hua Zhang; Elizabeth Morse; Rosandra N Kaplan; Crystal L Mackall
Journal:  Sci Transl Med       Date:  2014-05-21       Impact factor: 17.956

2.  Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients.

Authors:  Tullia C Bruno; Peggy J Ebner; Brandon L Moore; Olivia G Squalls; Katherine A Waugh; Evgeniy B Eruslanov; Sunil Singhal; John D Mitchell; Wilbur A Franklin; Daniel T Merrick; Martin D McCarter; Brent E Palmer; Jeffrey A Kern; Jill E Slansky
Journal:  Cancer Immunol Res       Date:  2017-08-28       Impact factor: 11.151

Review 3.  The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.

Authors:  Vinit Kumar; Sima Patel; Evgenii Tcyganov; Dmitry I Gabrilovich
Journal:  Trends Immunol       Date:  2016-02-06       Impact factor: 16.687

4.  Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration.

Authors:  Jay M Lee; Mi-Heon Lee; Edward Garon; Jonathan W Goldman; Ramin Salehi-Rad; Felicita E Baratelli; Dörthe Schaue; Gerald Wang; Fran Rosen; Jane Yanagawa; Tonya C Walser; Ying Lin; Stacy J Park; Sharon Adams; Francesco M Marincola; Paul C Tumeh; Fereidoun Abtin; Robert Suh; Karen L Reckamp; Gina Lee; William D Wallace; Sarah Lee; Gang Zeng; David A Elashoff; Sherven Sharma; Steven M Dubinett
Journal:  Clin Cancer Res       Date:  2017-05-03       Impact factor: 12.531

5.  Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.

Authors:  Yong Wang; Cara C Schafer; Kenneth P Hough; Sultan Tousif; Steven R Duncan; John F Kearney; Selvarangan Ponnazhagan; Hui-Chen Hsu; Jessy S Deshane
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422

Review 6.  B regulatory cells in cancer.

Authors:  Frances Balkwill; Anne Montfort; Melania Capasso
Journal:  Trends Immunol       Date:  2012-12-01       Impact factor: 16.687

7.  IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer.

Authors:  Asa Andersson; Seok-Chul Yang; Min Huang; Li Zhu; Upendra K Kar; Raj K Batra; David Elashoff; Robert M Strieter; Steven M Dubinett; Sherven Sharma
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

8.  Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.

Authors:  Dhifaf Sarhan; Frank Cichocki; Bin Zhang; Ashley Yingst; Stephen R Spellman; Sarah Cooley; Michael R Verneris; Bruce R Blazar; Jeffrey S Miller
Journal:  Cancer Res       Date:  2016-08-08       Impact factor: 12.701

Review 9.  The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironment.

Authors:  Francesco De Sanctis; Sara Sandri; Giovanna Ferrarini; Irene Pagliarello; Silvia Sartoris; Stefano Ugel; Ilaria Marigo; Barbara Molon; Vincenzo Bronte
Journal:  Front Immunol       Date:  2014-02-24       Impact factor: 7.561

10.  CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.

Authors:  Colin W Steele; Saadia A Karim; Joshua D G Leach; Peter Bailey; Rosanna Upstill-Goddard; Loveena Rishi; Mona Foth; Sheila Bryson; Karen McDaid; Zena Wilson; Catherine Eberlein; Juliana B Candido; Mairi Clarke; Colin Nixon; John Connelly; Nigel Jamieson; C Ross Carter; Frances Balkwill; David K Chang; T R Jeffry Evans; Douglas Strathdee; Andrew V Biankin; Robert J B Nibbs; Simon T Barry; Owen J Sansom; Jennifer P Morton
Journal:  Cancer Cell       Date:  2016-06-02       Impact factor: 38.585
View more
  2 in total

1.  Participation of Increased Circulating MAIT Cells in Lung Cancer: a Pilot Study.

Authors:  Qian Zhang; Pengli Li; Wenqin Zhou; Shu Fang; Jiong Wang
Journal:  J Cancer       Date:  2022-03-06       Impact factor: 4.207

Review 2.  Interaction between Immunotherapy and Antiangiogenic Therapy for Cancer.

Authors:  Koichi Furukawa; Tatsuya Nagano; Motoko Tachihara; Masatsugu Yamamoto; Yoshihiro Nishimura
Journal:  Molecules       Date:  2020-08-26       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.